Accenture Plc · NYSE:ACN
Accenture — Investor Presentation (February 2024)
16 slides from Accenture's investor presentation, February 2024
Slide 1: Accenture Regulatory Capabilities
Accenture Regulatory Capabilities
Slide 2: Accenture Life Sciences Regulatory Practice
Accenture Life Sciences Regulatory Practice Our Regulatory Practice at Accenture is comprehensive, including innovative consulting experience, proven-digital/technology capability, and industry-leading operations services Strategy / Consulting Technology Operations • Technology / Data strategy and r
Slide 3: Regulatory Offerings for Biopharma
Regulatory Offerings for Biopharma Providing Regulatory services for 23+ years Regulatory Process, Tools & Experience Submission Strategy & Author Technical Compile & Format Publish & Submit & Manage Health Archiving & Submission Content Plan Documents Dossier Dispatch Authority Interactions Trackin
Slide 4: Our Global Footprint
Our Global Footprint Regulatory Affairs Submission/ Strategy Consulting • Clinical development strategy • Global drug registration strategy • Scientific advice and agency meetings • Lifecycle Management (LCM) strategy • Regulatory intelligence Regulatory Compliance & Data Management • CMC and Labeli
Slide 5: Overall Regulatory Services – Factsheet
Overall Regulatory Services – Factsheet 250+ 2,650+ Provided strategic registration advice to 23+ skilled Regulatory professionals Years SPL transactions (Jan. 2012 to date) ~50 companies of Regulatory Operations Experience 26+ therapeutic areas 1,000+ 10,000+ CMC dossier Health Authority 4,000+ bas
Slide 6: Our Regulatory Operations Services
Our Regulatory Operations Services Structured Product Clinical Trial Data Submission Document Submission Labeling (SPL) Transparency / Redaction Management Publishing Publishing Services (EMA Policy 0070 & HC PRCI) Creation and management of Document Publishing / Our services include Structured Prod
Slide 7: Our Regulatory Affairs Services
Our Regulatory Affairs Services Chemistry, Lifecycle Labeling US Agent Clinical Trials Identification of Manufacturing Management Services Regulation Medicinal and Controls (CMC) (LCM) (CTR) Services Product (IDMP) CMC authoring, review Supports pharmaceutical Labeling management US Agents and Liais
Slide 8: Our Medical Writing Services
Our Medical Writing Services Clinical Strategic Regulatory Writing Real World Scientific Writing Consultancy (Dossier support) Studies Communications Clinical Protocols Investigator’s Brochures Clinical Overviews and PMS Studies Manuscripts and Review Articles – Strategic Study Design, – First Versi
Slide 9: R&D Offerings for Consumer Products
R&D Offerings for Consumer Products Accenture provides robust set of R&D Services for Consumer Goods Clients Labeling Artwork Registrations Supplier Spec Data Mgmt. Cosmetovigilance • This is the process of • Artwork is the translation • The Registration Process • Process includes • Centralized Spec
Slide 10: Regulatory Submissions Support – seamless project ramp-up and noiseless delivery
Regulatory Submissions 100% Support – seamless For TAT compliance project ramp-up and noiseless delivery <1% A top multinational biopharma company was in the Errors calculated monthly market for a Regulatory submissions support vendor able to handle higher submission volumes along with a higher focu
Slide 11: Regulatory Submissions Support – seamless end-to-end submission process
Regulatory Submissions 99.9% Support – seamless end- For TAT compliance to-end submission process with high compliance <1% Errors calculated monthly A top multinational biotechnology company, with a portfolio of 48 compounds/products, was in the market for a partner with higher quality delivery and
Slide 12: Regulatory Renewals – Seamless end-to-end Regulatory Project Management Support
Regulatory Renewals – 99.9% Seamless end-to-end For TAT compliance Regulatory Project Management Support 14 FTE A top multinational pharmaceutical company, with a portfolio of ~1400+ renewal submissions annually, was in the market for a partner with higher quality delivery and better customer servic
Slide 13: Regulatory Innovation Services & Automation
Regulatory Innovation Services & Automation Regulatory Innovation Services Regulatory Automation Transforming regulatory through automation Challenging orthodoxies and shaping the future • Robotics capability assessment • Breakthrough design thinking workshops • Process automation assessment • Ideat
Slide 14: Global Pharma Company: Next Generation Labeling
Global Pharma Company: Next Generation Labeling Business Background and Challenge • This Next Generation Labelling capability project was initiated to improve pharmaceutical labeling and patient safety for a large global bio-pharma company. • The project objective was to provide a smarter approach t
Slide 15: Automated Translation Tool
Automated Translation Tool Fast, consistent, clinical-domain translations reduce costs Business Challenge Translation is mandatory and costly. Machine translation is available from many vendors, but Key Outcomes / Benefits the clinical domain is challenging for out-of-the-box machine translation sol
Slide 16: iACTIVATE makes the perfect tool for transforming R&D operations into a digital platform
iACTIVATE makes the perfect tool for transforming R&D operations into a digital platform Business Challenge Artwork Proofreading is the process of verifying the accuracy of the agreed graphic elements against Key Outcomes / Benefits the necessary documentation inputs (e.g., PLR), including Nutrition